Phosphodiesterase 4 inhibitor regulates the TRANCE/OPG ratio via COX-2 expression in a manner similar to PTH in osteoblasts

Hyojung Park, Soo Young Lee, Dong Seok Lee, Mijung Yim

Research output: Contribution to journalArticlepeer-review

15 Scopus citations

Abstract

Phosphodiesterase 4 (PDE4) inhibitors stimulate osteoclast formation by increasing the TRANCE/OPG mRNA ratio via cAMP-mediated pathways in a manner similar to parathyroid hormone (PTH) in osteoblasts. We investigated the role of cyclooxygenase-2 (COX-2) in osteoclast formation induced by the PDE4 inhibitor rolipram. Rolipram induced COX-2 expression in mRNA and protein levels, followed by increased prostaglandin E2 production in osteoblasts. PKA, ERK, and p38 MAPK pathways regulate COX-2 mRNA expression induced by rolipram, in which PKA is a central regulator of the ERK and p38 MAPK pathways. A COX-2 inhibitor reversed the up-regulation of the TRANCE/OPG mRNA ratio induced by rolipram in osteoblasts, resulting in decreased osteoclast formation. These data suggest that COX-2 mediates rolipram induced osteoclast formation by regulating the TRANCE/OPG mRNA ratio in osteoblasts. Furthermore, the effects of the PDE4 inhibitor on osteoblasts were very similar to those of PTH, indicating that the PDE4 inhibitor largely shares the biological actions of PTH in osteoblasts.

Original languageEnglish
Pages (from-to)178-183
Number of pages6
JournalBiochemical and Biophysical Research Communications
Volume354
Issue number1
DOIs
StatePublished - 2 Mar 2007

Keywords

  • COX-2
  • OPG
  • Osteoblast
  • Osteoclast
  • Parathyroid hormone
  • Phosphodiesterase 4
  • TRANCE

Fingerprint

Dive into the research topics of 'Phosphodiesterase 4 inhibitor regulates the TRANCE/OPG ratio via COX-2 expression in a manner similar to PTH in osteoblasts'. Together they form a unique fingerprint.

Cite this